“FROM SERUM DYSLIPIDEMIA TO MACROPHAGE LIPID REMODELING IN VISCERAL LEISHMANIASIS: CHOLESTEROL TRAFFICKING, IMMUNOMETABOLIC REPROGRAMMING, AND THERAPEUTIC OPPORTUNITIES”. ISIR Journal of Business and Management Studies (ISIRJBMS) 3, no. 5 (October 31, 2026): 45–55. Accessed November 17, 2026. https://isirpublisher.com/index.php/isirjbms/article/view/48.